Medtronic (MDT) Depreciation and Depletion (2024 - 2026)

Medtronic has disclosed Depreciation and Depletion across 3 years of filings, most recently posting $308.0 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $308.0 million, up 14.93% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.2 billion (changed N/A YoY), and the FY2025 annual result was $1.1 billion, up 15.3% from the prior year.
• Depreciation and Depletion came in at $308.0 million for Q1 2026 at Medtronic, up from $282.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $322.0 million in Q2 2025 to a low of $248.0 million in Q3 2024.
• The 3-year median for Depreciation and Depletion is $282.0 million (2025), against an average of $282.7 million.
• Peak annual rise in Depreciation and Depletion reached 16.53% in 2025, while the deepest fall reached 7.63% in 2025.
• Medtronic's Depreciation and Depletion stood at $262.0 million in 2024, then advanced by 7.63% to $282.0 million in 2025, then grew by 9.22% to $308.0 million in 2026.
• The last three Depreciation and Depletion figures came in at $308.0 million (Q1 2026), $282.0 million (Q4 2025), and $289.0 million (Q3 2025), per Business Quant data.